Triple Injection Peri-sartorius (TIPS) Block
1 other identifier
interventional
80
1 country
1
Brief Summary
Comparison between the pain scores after total knee arthroplasty in patients receiving triple injection peri-sartorius (TIPS) block versus femoral nerve block (FNB)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2022
CompletedFirst Posted
Study publicly available on registry
March 21, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2023
CompletedMarch 10, 2023
March 1, 2023
11 months
March 13, 2022
March 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analogue scale (resting and dynamic, 11 point scale from 0 - 10 where 0 accounts for no pain and 10 accounts for worst pain)
Compare the two groups regarding the visual analogue scale scores
24 hours postoperatively
Secondary Outcomes (3)
Total postoperative morphine consumption
24 hours postoperatively
Operated limb motor power
24 hours postoperatively
Complications
24 hours
Study Arms (2)
TIPS Block
EXPERIMENTALGroup TIPS; patients will receive ultrasound guided triple injection peri-sartorius block preoperatively before surgical incision
FNB
ACTIVE COMPARATORGroup FNB; patients will receive femoral nerve block (FNB) before surgical incision
Interventions
Patients will receive ultrasound guided triple injection peri-sartorius block preoperatively before surgical incision
Patients will receive femoral nerve block (FNB) before surgical incision
Eligibility Criteria
You may not qualify if:
- BMI \> 35 kg/m2, Pre-existing neurological deficit, Any disability of the non-operated limb preventing fair mobilization, Known contraindications to peripheral nerve block (coagulopathy or infection at the site of injection), Chronic opioid users/abusers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria Faculty of Medicine
Alexandria, 21651, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2022
First Posted
March 21, 2022
Study Start
April 1, 2022
Primary Completion
March 7, 2023
Study Completion
March 7, 2023
Last Updated
March 10, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After statistical analysis
- Access Criteria
- Any
Individual participant data that underlie the resultsrepoted in this article after deidentification (text, tables, figures, and appendices)